# Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers

> **NCT00467493** · PHASE2 · COMPLETED · sponsor: **Meditrina Pharmaceuticals** · enrollment: 64 (actual)

## Conditions studied

- Menstruation Disorders

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00467493
- **Lead sponsor:** Meditrina Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2009-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467493, "Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00467493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*